The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Lipid abnormalities in renal disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Accelerated Atherosclerosis in Prolonged Maintenance Hemodialysis
Lindner, A., Charra, B., Sherrard, D. J., & Scribner, B. H. (1974) · New England Journal of Medicine · doi:10.1056/nejm197403282901301 · Cited by 1,776
KANNEL, W. B., CASTELLI, W. P., & GORDON, T. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-1-85 · Cited by 1,311
Rosenman, R. H. (1975) · JAMA · doi:10.1001/jama.233.8.872 · Cited by 1,268
Cohen, L. S., Elliott, W. C., Klein, M. D., & Gorlin, R. (1966) · The American Journal of Cardiology · doi:10.1016/0002-9149(66)90347-x · Cited by 1,223
LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE
Moorhead, J. F., El-Nahas, M., Chan, M. K., & Varghese, Z. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91513-6 · Cited by 1,070
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
Carlson, L., & Böttiger, L. E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90738-6 · Cited by 752
Hulley, S. B., Rosenman, R. H., Bawol, R. D., & Brand, R. J. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006193022503 · Cited by 702 · cited 1×
“not [12—14].”
ACRODERMATITIS ENTEROPATHICA: A LETHAL INHERITED HUMAN ZINC-DEFICIENCY DISORDER
Moynahan, E. J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91772-3 · Cited by 623
Probucol inhibits oxidative modification of low density lipoprotein.
Parthasarathy, S., Young, S. G., Witztum, J. L., Pittman, R. C., & Steinberg, D. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112349 · Cited by 618
Coronary heart disease in the Western Collaborative Group Study
Rosenman, R. H., Friedman, M., Straus, R., Jenkins, C. D., Zyzanski, S. J., & Wurm, M. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90094-9 · Cited by 445
Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats
Kasiske, B. L., O'donnell, M. P., Cleary, M. P., & Keane, W. F. (1988) · Kidney International · doi:10.1038/ki.1988.51 · Cited by 409
Focal and segmental glomerulosclerosis: Analogies to atherosclerosis
Diamond, J. R., & Karnovsky, M. J. (1988) · Kidney International · doi:10.1038/ki.1988.87 · Cited by 330
The Nephrotic Syndrome: A Complication of Massive Obesity
WEISINGER, J. R., KEMPSON, R. L., ELDRIDGE, F. L., & SWENSON, R. S. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-440 · Cited by 318
Bjørneboe, M., & Prytz, H. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91720-1 · Cited by 302
Arterial calcification and pathology in uremic patients undergoing dialysis
Ibels, L. S., Alfrey, A. C., Huffer, W. E., Craswell, P. W., Anderson, J. T., & Weil, R. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)91118-5 · Cited by 297
Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac Transplantation
(1988) · New England Journal of Medicine · doi:10.1056/nejm198801073180111 · Cited by 292
Kasiske, B. L., O'Donnell, M. P., Garvis, W. J., & Keane, W. F. (1988) · Circulation Research · doi:10.1161/01.res.62.2.367 · Cited by 291
Renal injury of diet-induced hypercholesterolemia in rats
Kasiske, B. L., O'Donnell, M. P., Schmitz, P. G., Kim, Y., Keane, W. F., Phillips, W. T. T. A. O. F., Daniels, F., & Holden, G. (1990) · Kidney International · doi:10.1038/ki.1990.62 · Cited by 268
Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving Lovastatin
(1988) · New England Journal of Medicine · doi:10.1056/nejm198801073180110 · Cited by 255
SERUM LIPID AND LIPOPROTEIN ALTERATIONS IN NEPHROSIS
Baxter, J. H., Goodman, H. C., & Havel, R. J. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104058 · Cited by 253
Lipid abnormalities in uremia, dialysis, and transplantation
Chan, M. K., Varghese, Z., & Moorhead, J. F. (1981) · Kidney International · doi:10.1038/ki.1981.62 · Cited by 227
Appel, G. B., Blum, C. B., Chien, S., Kunis, C. L., & Appel, A. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506133122404 · Cited by 219
Self-citationIschemic heart disease in patients with uremia undergoing maintenance hemodialysis
Rostand, S. G., Gretes, J. C., Kirk, K. A., Rutsky, E. A., & Andreoli, T. E. (1979) · Kidney International · doi:10.1038/ki.1979.170 · Cited by 218
Lipids and Progressive Glomerulosclerosis
Keane, W. F., Kasiske, B. L., & O’Donnell, M. P. (1988) · American Journal of Nephrology · doi:10.1159/000167599 · Cited by 202
LIPID ABNORMALITIES IN CYCLOSPORINE-PREDNISONE-TREATED RENAL TRANSPLANT RECIPIENTS
VATHSALA, A., WEINBERG, R. B., SCHOENBERG, L., GREVEL, J., GOLDSTEIN, R. A., VAN BUREN, C. T., LEWIS, R. M., & KAHAN, B. D. (1989) · Transplantation · doi:10.1097/00007890-198907000-00009 · Cited by 200
The role of hypertension in hemodialysis-associated atherosclerosis
Vincenti, F., Amend, W. J., Abele, J., Feduska, N. J., & Salvatierra, O. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90104-7 · Cited by 196
ANTIGLUCOCORTICOID ACTIONS OF DEHYDROEPIANDROSTERONE AND LOW CONCENTRATIONS IN ALZHEIMER'S DISEASE
Svec, F., & Lopez-S, A. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91940-5 · Cited by 192
Acute Muscular Syndrome Associated with Administration of Clofibrate
Langer, T., & Levy, R. I. (1968) · New England Journal of Medicine · doi:10.1056/nejm196810172791604 · Cited by 188
Plasma High-Density Lipoprotein Concentrations in Chronic-Hemodialysis and Renal-Transplant Patients
Bagdade, J. D., & Albers, J. J. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706232962504 · Cited by 181
Prevalence of serum lipid abnormalities in chronic hemodialysis
Brunzell, J. D., Albers, J. J., Haas, L. B., Goldberg, A. P., Agadoa, L., & Sherrard, D. J. (1977) · Metabolism · doi:10.1016/0026-0495(77)90009-9 · Cited by 179
Persistent Hyperlipidemia in Renal Transplant Patients
Kasiske, B. L., & Umen, A. J. (1987) · Medicine · doi:10.1097/00005792-198707000-00003 · Cited by 154
Lipoprotein Glomerulopathy: Glomerular Lipoprotein Thrombi in a Patient With Hyperlipoproteinemia
Saito, T., Sato, H., Kudo, K.-I., Oikawa, S.-I., Shibata, T., Hara, Y., Yoshinaga, K., & Sakaguchi, H. (1989) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(89)80134-9 · Cited by 148
Harris, K. P. G., Purkerson, M. L., Yates, J., & Klahr, S. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80587-7 · Cited by 146
Defective Triglyceride Removal in Lipemia Associated with Peritoneal Dialysis and Haemodialysis
Cattran, D. C., FENTON, S. S. A., WILSON, D. R., & STEINER, G. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-1-29 · Cited by 143
Hepatic Secretion of Lipoproteins in the Rat and the Effect of Experimental Nephrosis
Marsh, J. B., & Sparks, C. E. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109577 · Cited by 142
The Nephrotic Syndrome and Its Complications
Cameron, J. S. (1987) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(87)80170-1 · Cited by 139
Huttunen, J. K., Frick, M. H., Heinonen, O. P., Heinsalmi, P., Manninen, V., Mänttäri, M., & Romo, M. (1988) · Drugs · doi:10.2165/00003495-198800363-00009 · Cited by 132
COMPLICATIONS DURING CLOFIBRATE TREATMENT OF NEPHROTIC-SYNDROME HYPERLIPOPROTEINÆMIA
Bridgman, J. F., Rosen, S. M., & Thorp, J. M. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91905-8 · Cited by 130
Lovastatin therapy in nephrotic hyperlipidemia: Effects on lipoprotein metabolism
Vega, G. L., & Grundy, S. M. (1988) · Kidney International · doi:10.1038/ki.1988.125 · Cited by 128
Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure
Akmal, M., Kasim, S. E., Soliman, A. R., & Massry, S. G. (1990) · Kidney International · doi:10.1038/ki.1990.58 · Cited by 123
ISCHIEMIC HEART-DISEASE AS A COMPLICATION OF NEPHROTIC SYNDROME
Berlyne, G. M., & Mallick, N. P. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90110-x · Cited by 120
Hyperlipidemia After Renal Transplantation: Natural History and Pathophysiology
Cattran, D. C., STEINER, G., WILSON, D. R., & FENTON, S. S. A. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-4-554 · Cited by 117
Gherardi, E., Rota, E., Calandra, S., GENOVA, R., & Tamborino, A. M. (1977) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1977.tb01652.x · Cited by 113
Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients
Chan, M. K., Persaud, J. W., Varghese, Z., & Moorhead, J. F. (1984) · Kidney International · doi:10.1038/ki.1984.94 · Cited by 113
Harris, K. P. G., Russell, G. I., Parvin, S. D., Veitch, P. S., & Walls, J. (1986) · BMJ · doi:10.1136/bmj.292.6512.16 · Cited by 108
Glomerular disease in hypercholesterolemia guinea pigs: A pathogenetic study
Al-Shebeb, T. H., Frohlich, J., & Magil, A. B. (1988) · Kidney International · doi:10.1038/ki.1988.26 · Cited by 103
Serum Lipids and Lipoproteins during Continuous Ambulatory Peritoneal Dialysis
Lindholm, B., & Norbeck, H. E. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02742.x · Cited by 103
Extrarenal complications of the nephrotic syndrome
Bernard, D. B. (1988) · Kidney International · doi:10.1038/ki.1988.129 · Cited by 102
Oral contraceptives, venous thromboembolic disease, and ABO blood type
Westerholm, B., Wiechel, B., & Eklund, G. (1971) · The Lancet · doi:10.1016/s0140-6736(71)80108-3 · Cited by 102
Albumin synthesis, albuminuria and hyperlipemia in nephrotic patients
Kaysen, G. A., Gambertoglio, J. G., Felts, J. M., & Hutchison, F. N. (1987) · Kidney International · doi:10.1038/ki.1987.151 · Cited by 99
Hahn, R. T., Oette, K., Mondorf, H., Finke, K., & Sieberth, H. G. (1983) · Atherosclerosis · doi:10.1016/0021-9150(83)90045-x · Cited by 96
Status of the coronary arteries in the nephrotic syndrome
Curry, R. C., & Roberts, W. C. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90231-5 · Cited by 95
Management of hyperlipidemia of kidney disease
Grundy, S. M. (1990) · Kidney International · doi:10.1038/ki.1990.57 · Cited by 95
Goldberg, A. P., Applebaum-Bowden, D. M., Bierman, E. L., Hazzard, W. R., Haas, L. B., Sherrard, D. J., Brunzell, J. D., Huttunen, J. K., Ehnholm, C., & Nikkilä, E. A. (1979) · New England Journal of Medicine · doi:10.1056/nejm197911153012001 · Cited by 94
Hamazaki, T., Nakazawa, R., Tateno, S., Shishido, H., Isoda, K., Hattori, Y., Yoshida, T., Fujita, T., Yano, S., & Kumagai, A. (1984) · Kidney International · doi:10.1038/ki.1984.137 · Cited by 89
Rabelink, T. J., Erkelens, D. W., Hené, R. J., Joles, J. A., & Koomans, H. A. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90870-7 · Cited by 87
McKenzie, I. F. C., & Nestel, P. J. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105859 · Cited by 85
Lecithin-cholesterol acyltransferase (LCAT) activity in chronic uremia.
Guarnieri, G., Moracchiello, M., Campanacci, L., Ursini, F., Ferri, L., Valente, M., & Gregolin, C. S. (1978) · PubMed · Cited by 85
Effects of dietary fish oil on renal insufficiency in rats with subtotal nephrectomy
Scharschmidt, L. A., Gibbons, N., McGarry, L., Berger, P., Axelrod, M., Janis, R., & Ko, Y. H. (1987) · Kidney International · doi:10.1038/ki.1987.263 · Cited by 76
Lipoproteins and Apolipoproteins during the Progression of Chronic Renal Disease
Grützmacher, P., März, W., Peschke, B., Gross, W., & Schoeppe, W. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000185138 · Cited by 75
DOES THE NEPHROTIC SYNDROME INCREASE THE RISK OF CARDIOVASCULAR DISEASE?
Wass, V., Chilvers, C. E. D., Jarrett, R. J., & Cameron, J. S. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92067-1 · Cited by 69
Putative atherogenic factors in patients with chronic renal failure
Green, D., Stone, N. J., & Krumlovsky, F. A. (1983) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(83)90027-0 · Cited by 64
Lipid and apolipoprotein levels in patients with nephrotic syndrome
Takao, O., & Ichito, M. (1981) · Clinica Chimica Acta · doi:10.1016/0009-8981(81)90034-6 · Cited by 64
Response of plasma triglycerides to dietary change in patients on hemodialysis
Sanfelippo, M. L., Swenson, R. S., & Reaven, G. M. (1978) · Kidney International · doi:10.1038/ki.1978.105 · Cited by 62
Alexander, J. H., Schapel, G. J., & Edwards, K. D. G. (1974) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1974.tb93641.x · Cited by 59
Savdie, E., Gibson, J. C., Crawford, G. A., Simons, L. A., & Mahony, J. F. (1980) · Kidney International · doi:10.1038/ki.1980.196 · Cited by 55
Lipid Disorders in Renal Transplant Recipients
Ponticelli, C. E., Barbi, G. L., Cantaluppi, A., Vecchi, A. D., Annoni, G. A., Donati, C., & Cecchettin, M. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000181221 · Cited by 55
The Effects of Lovastatin in Hyperlipidemic Patients With the Nephrotic Syndrome
Kasiske, B. L., Velosa, J. A., Halstenson, C. E., Belle, P. L., Langendörfer, A., & Keane, W. F. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80586-5 · Cited by 55
Gherardi, E., Vecchia, L., & Calandra, S. (1980) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(80)90049-0 · Cited by 55
Carnitine Metabolism in Chronic Renal Failure
Guarnieri, G., Toigo, G., Crapesi, L., Situlin, R., Bianco, M. A. D., Corsi, M., Greco, P. L., & Vasile, A. (2015) · Contributions to nephrology · doi:10.1159/000415742 · Cited by 55
Hyperlipidemia after organ transplantation.
Ms, M., & Ea, F. (1989) · PubMed · Cited by 54
Calandra, S., Gherardi, E., Fainaru, M., Guaitani, A., & Bartosek, I. (1981) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(81)90018-7 · Cited by 54
Effect of alternate-day prednisone on plasma lipids in renal transplant recipients
Curtis, J. J., Galla, J. H., Woodford, S. Y., Lucas, B. A., & Luke, R. G. (1982) · Kidney International · doi:10.1038/ki.1982.130 · Cited by 54
Lovastatin in the Treatment of Multifactorial Hyperlipidemia Associated With Proteinuria
Golper, T. A., Illingworth, D. R., Morris, C. D., & Bennett, W. M. (1989) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(89)80038-1 · Cited by 53
Serum and urinary high density lipoproteins in glomerular disease with proteinuria
Short, C. D., Durrington, P. N., Mallick, N. P., Hunt, L. P., Tetlow, L. J., & Ishola, M. (1986) · Kidney International · doi:10.1038/ki.1986.131 · Cited by 53
Allen, J. C., Baxter, J. H., & Goodman, H. C. (1961) · Journal of Clinical Investigation · doi:10.1172/jci104277 · Cited by 52
Interactions of low density lipoprotein with rat mesangial cells
Wasserman, J., Santiago, A., Rifici, V. A., Holthöfer, H., Scharschmidt, L. A., Epstein, M., & Schlöndorff, D. (1989) · Kidney International · doi:10.1038/ki.1989.106 · Cited by 51
Pasternack, A. I., Vänttinen, T., Solakivi, T., Kuusi, T., & Korte, T. (1987) · PubMed · Cited by 51
Treatment of the Hyperlipidemia of the Nephrotic Syndrome: A Controlled Trial
Valeri, A. M., Gelfand, J. L., Blum, C. B., & Appel, G. B. (1986) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(86)80164-0 · Cited by 50
Self-citationTreatment of nephrotic hyperlipoproteinemia with gemfibrozil
Groggel, G. C., Cheung, A. K., Ellis-Benigni, K., & Wilson, D. E. (1989) · Kidney International · doi:10.1038/ki.1989.189 · Cited by 45
Dialysis hyperlipemia: response to dietary manipulations.
Dc, C., Steiner, G. E., Ss, F., et al. (1980) · PubMed · Cited by 40
Patient profile and effect of dietary therapy on post-transplant hyperlipidemia.
Sy, S., Cw, L., Alongi, S. V., Re, S., Dagher, F. J., & Jh, S. (1983) · PubMed · Cited by 33
Chronic Clofibrate Therapy in Maintenance Hemodialysis Patients
Sherrard, D. J., Goldberg, A. B., Haas, L. B., & Brunzell, J. D. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000181842 · Cited by 27
Avram, M. M. (1989) · PubMed · Cited by 26
Dietary treatment of hyperlipidemia in chronic hemodialysis patients
Gokal, R., Mann, J. I., Oliver, D. O., & Ledingham, J. G. G. (1978) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/31.10.1915 · Cited by 21
Gemfibrozil, Lipids, and Coronary Risk
Rifkind, B. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172008 · Cited by 17
Serum lipoprotein concentrations in chronic uremia
Norbeck, H. E., Orö, L., & Carlson, L. A. (1978) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/31.10.1881 · Cited by 15
Hyperlipidemia after renal transplantation in children on alternate day corticosteroid therapy.
Drukker, A., Turner, C., Start, K. M., Munian, A., Wass, V., Haycock, G. B., & CHANTLER, C. (1986) · PubMed · Cited by 12
Intraglomerular Lipid Deposition in Experimental Focal Glomerular Sclerosis in the Rat
Ohsawa, H., Yamabe, H., Ozawa, K., Fukushi, K., Kubota, H., Chiba, N., SOHMA, Y., Kanazawa, T., & Onodera, K. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000185122 · Cited by 5
Cited by
Muntner, P., Coresh, J., Smith, J. C., Eckfeldt, J., & Klag, M. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00165.x · Cited by 667
Lipoprotein Metabolism and Renal Failure
Attman, P.-O., Samuelsson, O., & Alaupovic, P. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80030-8 · Cited by 355
Lipoprotein metabolism and lipid management in chronic kidney disease
Kwan, B. C. H., Kronenberg, F., Beddhu, S., & Cheung, A. K. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091006 · Cited by 354
High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia
Kawagishi, T., Nishizawa, Y., Konishi, T., Kawasaki, K., Emoto, M., Shoji, T., Tabata, T., Inoue, T., & Morii, H. (1995) · Kidney International · doi:10.1038/ki.1995.356 · Cited by 311
The increased risk of coronary heart disease associated with nephrotic syndrome
Ordoñez, J. D., Hiatt, R. A., Killebrew, E. J., & Fireman, B. H. (1993) · Kidney International · doi:10.1038/ki.1993.292 · Cited by 296
Metadata
- Authors
- Appel, G.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 1991-01
- Volume
- 39
- Issue
- 1
- Pages
- 169-183
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2032700523
- Cited by
- 286
- References
- 94
- FWCI
- 24.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.